8:08AM ET 6/24/2022 MT NewswiresCytokinetics (CYTK) said Friday the US Food and Drug Administration's cardiovascular and renal drugs advisory committee will meet on Dec. 13 to review its...
4:31PM ET 6/17/2022 MT NewswiresRobert I Blum, Director, President & CEO, on June 15, 2022, sold 10,000 shares in Cytokinetics (CYTK) for $394,000. Following the Form 4 filing with the...
9:29AM ET 6/17/2022 MT NewswiresCytokinetics (CYTK) said Friday the US Food and Drug Administration has extended the Prescription Drug User Fee Act date for the company's new drug...
10:05AM ET 6/16/2022 MT NewswiresCytokinetics (CYTK) said Thursday it has started an open-label extension clinical study to assess the long-term safety and tolerability of reldesemtiv in...